Fundraising Fox

Endotronix

Woodridge, US · Delaware corporation · 6 known investors

Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure. The system enables clinicians to remotely optimize heart failure medication and supports patient self-monitoring.

Digital HealthHealthtechMedical Devices

Founders & leadership

HR
Harry RowlandCo-founder
AI
Anthony I NunezCo-founder
ANAnthony Nunez
Anthony NunezinFounder
AA
Anthony A. NunezNamed on SEC filing

Board

JJ
Jonathan JonasBoard director
RS
Raymond S. Barrett, Jr.Board director
SR
Sam R. LenoBoard director
LA
Leslie A. SaxonBoard director
JJ
James J. HummerBoard director

Investors · 6

Bioventures InvestorsWestborough · $15M – $100M
Jumpstart VenturesCleveland · $500K – $2M
Lumira VenturesToronto · $1M – $10Mvia Gerry Brunk · board
OSF VenturesPeoria
Seroba Life SciencesDublin · $540K – $7.6M
SV Health InvestorsBoston · $1M – $20Mvia Paul LaViolette · board

Reported raises · per SEC filings

Form D private placements

$113.1M disclosed across 5 rounds · 2014–2018

▶$69.3MraisedDec 2020 · 38 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Fouad AzzamDirector
  • John FlavinExecutive Officer
  • Robert ZieserlDirector
  • Paul LaVioletteDirector
  • Marc GoldbergDirector
  • Gerry BrunkDirector
  • James HummerDirector
  • Jennifer McMahonDirector
  • Harry RowlandExecutive Officer, Director
Offering amount
$90.8M
Amount sold
$69.3M
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.1MraisedFeb 2018 · 52 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul LaVioletteDirector
  • Gerry BrunkDirector
  • Robert ZieserlDirector
  • Harry RowlandExecutive Officer, Director
  • Kent ElmerExecutive Officer
  • Marc GoldbergDirector
  • James HummerDirector
  • Jennifer McMahonDirector
Offering amount
$37.1M
Amount sold
$37.1M
First sale
Jul 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedDec 2015 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan JonasDirector
  • Sam R. LenoDirector
  • Harry RowlandExecutive Officer, Director
  • Leslie SaxonDirector
  • Anthony I NunezExecutive Officer, Director
  • Raymond S. Barrett, Jr.Director
  • James J. HummerDirector
Offering amount
$3.5M
Amount sold
$3M
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedFeb 2015 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan JonasDirector
  • Harry RowlandExecutive Officer, Director
  • Raymond S. Barrett, Jr.Director
  • Anthony I NunezExecutive Officer, Director
  • Sam R. LenoDirector
  • Leslie A. SaxonDirector
  • James J. HummerDirector
Offering amount
$2.5M
Amount sold
$2.2M
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedApr 2014 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Harry RowlandExecutive Officer, Director
  • Sam R. LenoDirector
  • James J. HummerDirector
  • Leslie A. SaxonDirector
  • Anthony A. NunezExecutive Officer, Director
  • Raymond S. Barrett, Jr.Director
Offering amount
$3M
Amount sold
$1.6M
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Rf Surgical44 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Edwards Lifesciences31 shared keywords
Boston Scientific31 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies competing with Endotronix for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure - Lumira Ventures | Venture Capital Life Sciences | Canadalumiraventures.com · Sep 2018Endotronix Expands Funding with $12 Million in Debt Financing from Silicon Valley Bankprnewswire.com · Jan 2017Endotronix raises $32M Series C for heart failure management | Fierce Biotechfiercebiotech.com · Jul 2016Heart tech company Endotronix pumps in $32 million funding round – Chicago Tribunechicagotribune.com · Jul 2016

Frequently asked questions

What does Endotronix do?
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure. The system enables clinicians to remotely optimize heart failure medication and supports patient self-monitoring.
Who founded Endotronix?
Endotronix was founded by Harry Rowland, Anthony I Nunez, Anthony Nunez.
Who are Endotronix's investors?
Endotronix's investors include Bioventures Investors, Jumpstart Ventures, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors.
How much funding has Endotronix raised?
Endotronix has disclosed $113.1M raised across 5 rounds.
Where is Endotronix headquartered?
Endotronix is headquartered in Woodridge, US.